Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2021
Apyx Medical Corporation provided earnings guidance for the year ending December 31, 2021. For the year, the company expects total revenue in the range of $37.6 million to $39.7 million, representing growth of 36% to 43% year-over-year, compared to total revenue of $27.7 million for the year ended December 31, 2020 and net loss attributable to stockholders in the range of $20.3 million to $18.0 million, compared to net loss attributable to stockholders of $11.9 million for the year ended December 31, 2020.